vedolizumab
takeda
[' vedo', 'vedo', 'crohn', 'vedolizumab']
 prevention of postoperative recurrence of crohn's disease with vedolizumab: first results of the prospective placebo-controlled randomised trial reprevio
#ecco2023 
MD. Gastro
HURH.

                                                           For with thee is the fountain of life: in thy light shall we see light. Psalm 36:9